Roh V - Search Results

1

Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma.

Sibold S, Roh V, Keogh A, Studer P, Tiffon C, Angst E, Vorburger SA, Weimann R, Candinas D, Stroka D. Sibold S, et al. Among authors: roh v. FEBS Lett. 2007 Mar 6;581(5):989-94. doi: 10.1016/j.febslet.2007.01.080. Epub 2007 Feb 7. FEBS Lett. 2007. PMID: 17316623 Free article.

2

Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions.

Laemmle A, Lechleiter A, Roh V, Schwarz C, Portmann S, Furer C, Keogh A, Tschan MP, Candinas D, Vorburger SA, Stroka D. Laemmle A, et al. Among authors: roh v. PLoS One. 2012;7(3):e33433. doi: 10.1371/journal.pone.0033433. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479397 Free PMC article.

3

Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.

Roh V, Laemmle A, Von Holzen U, Stroka D, Dufour JF, Hunt KK, Candinas D, Vorburger SA. Roh V, et al. Cancer Gene Ther. 2008 Oct;15(10):636-44. doi: 10.1038/cgt.2008.34. Epub 2008 Jun 6. Cancer Gene Ther. 2008. PMID: 18535617

4

The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.

Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP. Jenal M, et al. Among authors: roh v. Mol Cancer Res. 2009 Jun;7(6):916-22. doi: 10.1158/1541-7786.MCR-08-0359. Epub 2009 Jun 2. Mol Cancer Res. 2009. PMID: 19491197

5

Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.

Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, Trochsler M, Hunt KK, Candinas D, Vorburger SA. Wagner M, et al. Among authors: roh v. J Gastrointest Surg. 2009 Oct;13(10):1781-90. doi: 10.1007/s11605-009-0948-x. Epub 2009 Jun 30. J Gastrointest Surg. 2009. PMID: 19565301 Free article.

6

Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.

Mermod M, Hiou-Feige A, Bovay E, Roh V, Sponarova J, Bongiovanni M, Vermeer DW, Lee JH, Petrova TV, Rivals JP, Monnier Y, Tolstonog GV, Simon C. Mermod M, et al. Among authors: roh v. Int J Cancer. 2018 Jun 15;142(12):2518-2528. doi: 10.1002/ijc.31240. Epub 2018 Jan 21. Int J Cancer. 2018. PMID: 29313973 Free article.

7

The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.

Roh V, Hiou-Feige A, Misetic V, Rivals JP, Sponarova J, Teh MT, Ferreira Lopes S, Truan Z, Mermod M, Monnier Y, Hess J, Tolstonog GV, Simon C. Roh V, et al. J Pathol. 2020 Jan;250(1):107-119. doi: 10.1002/path.5342. Epub 2019 Dec 3. J Pathol. 2020. PMID: 31465124

8

Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma.

Roh V, Abramowski P, Hiou-Feige A, Cornils K, Rivals JP, Zougman A, Aranyossy T, Thielecke L, Truan Z, Mermod M, Monnier Y, Prassolov V, Glauche I, Nowrouzi A, Abdollahi A, Fehse B, Simon C, Tolstonog GV. Roh V, et al. Cell Rep. 2018 Nov 20;25(8):2208-2222.e7. doi: 10.1016/j.celrep.2018.10.090. Cell Rep. 2018. PMID: 30463016 Free article.

9

CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.

Labiano S, Roh V, Godfroid C, Hiou-Feige A, Romero J, Sum E, Rapp M, Boivin G, Wyss T, Simon C, Bourhis J, Umaña P, Trumpfheller C, Tolstonog GV, Vozenin MC, Romero P. Labiano S, et al. Among authors: roh v. Clin Cancer Res. 2021 Jul 15;27(14):4054-4065. doi: 10.1158/1078-0432.CCR-20-4717. Epub 2021 Apr 26. Clin Cancer Res. 2021. PMID: 33903200

10

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model.

Domingos-Pereira S, Roh V, Hiou-Feige A, Galliverti G, Simon C, Tolstonog GV, Nardelli-Haefliger D. Domingos-Pereira S, et al. Among authors: roh v. Oncoimmunology. 2021 Apr 13;10(1):1912473. doi: 10.1080/2162402X.2021.1912473. Oncoimmunology. 2021. PMID: 33907631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page